Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort

CONCLUSIONS: Our RWD suggests that elderly patients, when compared to those under 70, experience similar survival outcomes and exhibit comparable tolerance for CDK4/6i therapy.PMID:38519708 | DOI:10.1007/s12094-024-03399-3

Source: Clinical Genitourinary Cancer - March 23, 2024 Category: Cancer & Oncology Authors: Helena Pla Eudald Felip Ver ónica Obadia Sonia Pernas Gemma Vi ñas Mireia Margel í Roser Fort-Culillas Sonia Del Barco Nuria Sabat é Eduard Fort Clara Lezcano Beatriz Cirauqui Vanesa Quiroga Agostina Stradella Miguel Gil Gil Anna Esteve Sabela Recalde Source Type: research